Latest news with #TribunHealth
Yahoo
04-07-2025
- Health
- Yahoo
Versailles Hospital Center adopts digital pathology platform
The Versailles Hospital Center has begun a digital pathology transformation by selecting Tribun Health's CaloPix imaging platform. This move is a significant step in modernising the French public healthcare system's diagnostic services and integrating artificial intelligence (AI) into pathology. The implementation of CaloPix within the pathology department is set to streamline primary diagnostics and interdisciplinary collaboration. Tribun Health CEO Jean-François POMEROL said: 'This choice reflects a shared commitment to innovating for more effective, collaborative, and patient-centered healthcare.' Tribun Health's platform has a user-friendly interface and flexibility, catering to the dynamic requirements of hospital infrastructures. It is designed to be open and interoperable, allowing it to integrate with the hospital's digital strategy. This initiative is in line with the Versailles Hospital Center and GHT 78 Sud's digital objectives, which are coordinated with GHT Nord. It contributes to a national effort to upgrade and digitise healthcare facilities. Versailles Hospital Center is GHT 78 Sud's supporting institution. Versailles Hospital Center Pathology Department head Dr Claire GLASER said: 'The selection of CaloPix is fully aligned with our digital transformation strategy. We were impressed by the solution's user-friendliness, performance, and the quality of support offered by Tribun Health's teams. 'This project, developed in collaboration with the GHT Yvelines Nord, marks a key step for the future of our specialty in the region, particularly regarding AI and collaborative work. It also enhances our integration into APHP's expert networks equipped with the same software.' Tribun Health uses data-driven technology and AI to improve precision and minimise turnaround times to assist laboratories and hospitals in transitioning from glass slide pathology to complete digital solutions. "Versailles Hospital Center adopts digital pathology platform" was originally created and published by Hospital Management, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Miami Herald
03-07-2025
- Health
- Miami Herald
The Versailles Hospital Center Chooses Tribun Health for Its Transition to Digital Pathology
A Major Step Toward Precision Diagnostics with the Implementation of CaloPix® PARIS, FRANCE / ACCESS Newswire / July 3, 2025 / Tribun Health, European leader in AI-enhanced digital pathology, is proud to announce that the Versailles Hospital Center, the supporting institution of GHT 78 Sud, has selected its imaging platform, CaloPix®, to support the digital transformation of its pathology department. This decision represents a strategic milestone in modernizing diagnostic services within the French public healthcare system. Through this project, the Versailles Hospital Center joins a growing network of pioneering institutions leveraging Tribun Health's technologies to optimize workflows, enhance diagnostic quality, and prepare for the integration of artificial intelligence. "We are honored by the trust that the Versailles Hospital Center has placed in us," said Jean-François POMEROL, CEO of Tribun Health. "This choice reflects a shared commitment to innovating for more effective, collaborative, and patient-centered healthcare." "The selection of CaloPix® is fully aligned with our digital transformation strategy," explained Dr. Claire GLASER, Head of the Pathology Department at the Versailles Hospital Center. "We were impressed by the solution's user-friendliness, performance, and the quality of support offered by Tribun Health's teams. This project, developed in collaboration with the GHT Yvelines Nord, marks a key step for the future of our specialty in the region, particularly regarding AI and collaborative work. It also enhances our integration into APHP's expert networks equipped with the same software." CaloPix® will be deployed throughout the pathology department to support primary diagnostics, interdisciplinary collaboration, and the future integration of AI solutions. Known for its intuitive interface, high performance, and adaptability to the evolving needs of hospital structures, the platform is open and interoperable. This project is fully aligned with the digital strategy of the Versailles Hospital Center and GHT 78 Sud, in collaboration with GHT Nord, and reflects a national plan aimed at modernizing and digitizing healthcare infrastructures. It is also part of a strong regional initiative and will serve as an interoperability foundation within the GHTs of the Yvelines region. About Tribun Health Tribun Health, recognized under the French Tech 2030 label, is a global leader in digital pathology, offering award-winning solutions that improve workflow efficiency, diagnostic accuracy, and patient outcomes. We assist hospitals and laboratories in transitioning from glass slide pathology to fully digital solutions, leveraging AI and data-driven technology to enhance precision and reduce turnaround times. Our mission is simple: to ensure every cancer patient receives a timely and informed diagnosis-because every moment counts. By advancing pathology with cutting-edge innovations, we are shaping the future of cancer care. For more information, visit Tribun Health and follow us on LinkedIn and X. Contact Information Andreia Beyer VP, Global Marketing & Managing Director, North Americaabeyer@ (416) 565-0474 SOURCE: Tribun Health press release
Miami Herald
21-05-2025
- Business
- Miami Herald
CORRECTING and REPLACING: Tribun Health Achieves FDA Clearance for CaloPix Digital Pathology Platform With Dual Scanner Compatibility
[CORRECTED RELEASE] Updated to clarify reference to dual-scanner FDA clearance. PARIS, FRANCE / ACCESS Newswire / May 21, 2025 / Tribun Health, a leader in digital pathology, proudly announces that its flagship web-based image management system, CaloPix®, has received FDA 510(k) clearance for use with two leading whole slide imaging scanners: the Hamamatsu NanoZoomer S360MD and the Leica Aperio GT450 DX. This double clearance is representing a major step forward for the U.S. adoption of vendor-agnostic, enterprise-grade solutions. This clearance builds on CaloPix's strong regulatory track record: the solution is CE-marked, Health Canada-approved, and trusted by more than 100 hospitals and laboratories across Europe and Canada. With over 1,000 active users of CaloPix® worldwide, this milestone underscores the platform's scalability, performance, and rapid adoption across diverse healthcare systems. Now, with FDA clearance secured, Tribun Health is ready to bring its proven enterprise solution to hospitals and labs across the United States. Besides these regulatory achievements, CaloPix® has also been recognized three times as "Best in KLAS" for digital pathology, a global benchmark for excellence in healthcare IT. This prestigious recognition highlights Tribun Health's commitment to customer satisfaction, operational excellence, and product innovation. "This is a major commercial and clinical milestone for us," said Jean-François Pomerol, CEO of Tribun Health. "We're entering the U.S. with a solution that has already proven its value in demanding, high-throughput clinical environments. With CaloPix®, we offer a platform trusted by top-tier institutions, awarded Best in KLAS multiple times -and now validated by the FDA. As the market accelerates toward widespread clinical adoption, we're thrilled to expand our reach and solidify our position as a truly global player." Built for Enterprise, Designed for Performance, Ready for Cloud CaloPix® goes far beyond a traditional image viewer-it's a powerful, all-in-one digital pathology platform tailored for the needs of modern healthcare systems, large hospital networks, and academic institutions. Key capabilities include: Web-based, cloud-ready, zero-footprint architecture-no local installation required High-throughput case management and diagnostic reporting to streamline daily workflowsSeamless integration with LIS and VNA systems for unified data access across the enterpriseBuilt-in telepathology and remote collaboration tools for second opinions and network-wide consultationsArchiving, export, and quality control features to support regulatory compliance and research initiatives Meeting the Moment: Solving U.S. Market Challenges The U.S. faces a growing mismatch between rising pathology case volumes and a shrinking workforce. At the same time, there is a clear push for multi-site collaboration, integrated diagnostics, and precision medicine initiatives. With this FDA clearance, CaloPix® empowers U.S. hospitals and labs to: Digitize pathology workflows at scaleReduce turnaround times and improve reporting accuracyCollaborate remotely across institutionsPrepare for AI adoption with structured, interoperable data Building on our success with public health networks, cancer centers, academic hospitals and private laboratory groups across Europe and Canada, we are now ready to scale in the world's largest healthcare market-the United States. * CaloPix® is CE-marked, Health Canada-approved, and FDA 510(k) cleared. Please refer to the Instructions for Use (IFU) for intended purpose and regulatory indications. About Tribun Health Tribun Health is a global leader in digital pathology, offering award-winning solutions that improve workflow efficiency, diagnostic accuracy, and patient outcomes. We assist hospitals and laboratories in transitioning from glass slide pathology to fully digital solutions, leveraging AI and data-driven technology to enhance precision and reduce turnaround times. Our mission is simple: to ensure every cancer patient receives a timely and informed diagnosis-because every moment counts. By advancing pathology with cutting-edge innovations, we are shaping the future of cancer care. For more information, visit Tribun Health and follow us on LinkedIn and X. SOURCE: Tribun Health press release
Miami Herald
20-05-2025
- Business
- Miami Herald
Tribun Health Achieves FDA Clearance for CaloPix Digital Pathology Platform With Dual Scanner Compatibility
Paving the way for U.S. Market Entry and Global Expansion PARIS, FRANCE / ACCESS Newswire / May 20, 2025 / Tribun Health, a leader in digital pathology, proudly announces that its flagship web-based image management system, CaloPix®, has received FDA 510(k) clearance for use with two leading whole slide imaging scanners: the Hamamatsu NanoZoomer S360 and the Leica Aperio GT450. This marks the first time a digital pathology software has been cleared with both scanners, representing a major step forward for the U.S. adoption of vendor-agnostic, enterprise-grade solutions. This clearance builds on CaloPix's strong regulatory track record: the solution is CE-marked, Health Canada-approved, and trusted by more than 100 hospitals and laboratories across Europe and Canada. With over 1,000 active users of CaloPix® worldwide, this milestone underscores the platform's scalability, clinical reliability, and rapid adoption across diverse healthcare systems. Now, with FDA clearance secured, Tribun Health is ready to bring its proven enterprise solution to hospitals and labs across the United States. Besides these regulatory achievements, CaloPix® has also been recognized three times as "Best in KLAS" for digital pathology, a global benchmark for excellence in healthcare IT. This prestigious recognition highlights Tribun Health's commitment to customer satisfaction, operational excellence, and product innovation. "This is a major commercial and clinical milestone for us," said Jean-François Pomerol, CEO of Tribun Health. "We're entering the U.S. with a solution that has already proven its value in demanding, high-throughput clinical environments. With CaloPix®, we offer a platform trusted by top-tier institutions, awarded Best in KLAS multiple times -and now validated by the FDA. As the market accelerates toward widespread clinical adoption, we're thrilled to expand our reach and solidify our position as a truly global player." Built for Enterprise, Designed for Performance, Ready for Cloud CaloPix® goes far beyond a traditional image viewer-it's a powerful, all-in-one digital pathology platform tailored for the needs of modern healthcare systems, large hospital networks, and academic institutions. Key capabilities include: Web-based, Cloud ready, zero-footprint architecture-no local installation requiredHigh-throughput case management and diagnostic reporting to streamline daily workflowsSeamless integration with LIS and VNA systems for unified data access across the enterpriseBuilt-in telepathology and remote collaboration tools for second opinions and network-wide consultationsArchiving, export, and quality control features to support regulatory compliance and research initiatives Meeting the Moment: Solving U.S. Market Challenges The U.S. faces a growing mismatch between rising pathology case volumes and a shrinking workforce. At the same time, there is a clear push for multi-site collaboration, integrated diagnostics, and precision medicine initiatives. With this FDA clearance, CaloPix® empowers U.S. hospitals and labs to: Digitize pathology workflows at scaleReduce turnaround times and improve reporting accuracyCollaborate remotely across institutionsPrepare for AI adoption with structured, interoperable data Building on our success with public health networks, cancer centers, academic hospitals and private laboratory groups across Europe and Canada, we are now ready to scale in the world's largest healthcare market-the United States. * CaloPix® is CE mark, HC cleared, FDA cleared. Please refer to IFU for intended use. About Tribun Health Tribun Health is a global leader in digital pathology, offering award-winning solutions that improve workflow efficiency, diagnostic accuracy, and patient outcomes. We assist hospitals and laboratories in transitioning from glass slide pathology to fully digital solutions, leveraging AI and data-driven technology to enhance precision and reduce turnaround times. Our mission is simple: to ensure every cancer patient receives a timely and informed diagnosis-because every moment counts. By advancing pathology with cutting-edge innovations, we are shaping the future of cancer care. For more information, visit Tribun Health and follow us on LinkedIn and X. Contact Information Andreia Beyer VP, Global Marketing & Managing Director, North Americaabeyer@ (416) 565-0474 SOURCE: Tribun Health press release
Miami Herald
06-05-2025
- Health
- Miami Herald
Tribun Health Achieves ISO/IEC 27001 Certification, Strengthening Commitment to Data Security in Digital Pathology
Press Releases Tribun Health Achieves ISO/IEC 27001 Certification, Strengthening Commitment to Data Security in Digital Pathology Tribun Health, a leader in digital pathology software and AI-powered diagnostic solutions, is proud to announce that it has been awarded the ISO/IEC 27001 certification-an internationally recognized standard for information security management systems (ISMS). This achievement underscores Tribun Health's ongoing commitment to the highest standards of data protection, patient confidentiality, and operational excellence. In a field where security and privacy are non-negotiable, ISO 27001 certification validates that the company has implemented a robust framework to identify, manage, and reduce risks to sensitive information. "Our clients trust us with more than just images-they trust us with lives," said Zina Hamoumi, Chief Operating Officer at Tribun Health. "Achieving ISO 27001 reflects the discipline, structure, and dedication our teams bring to protecting that trust every single day." "This certification is not just a badge-it's a reflection of our core values," added Jean-François Pomerol, CEO of Tribun Health. "As we continue expanding globally, we remain deeply committed to earning and maintaining the confidence of our partners, customers, and the patients they serve." Used by pathology labs, hospitals, and healthcare networks worldwide, Tribun Health's CaloPix® platform manages millions of digital slides annually. As data volumes grow and collaboration across institutions increases, the need for stringent, transparent security measures becomes even more critical. ISO 27001 certification confirms that Tribun Health meets those standards, offering peace of mind to healthcare professionals and IT departments alike. Tribun Health continues to expand its footprint across Europe, North America and other regions, providing digital pathology platforms that are not only innovative but also safe and dependable. This certification builds on Tribun Health's long-standing commitment to data security, offering formal recognition of the rigorous controls already in place. About Tribun Health Tribun Health is a global leader in digital pathology, offering award-winning solutions that improve workflow efficiency, diagnostic accuracy, and patient outcomes. We assist hospitals and laboratories in transitioning from glass slide pathology to fully digital solutions, leveraging AI and data-driven technology to enhance precision and reduce turnaround times. Our mission is simple: to ensure every cancer patient receives a timely and informed diagnosis-because every moment counts. By advancing pathology with cutting-edge innovations, we are shaping the future of cancer care. For more information, visit Tribun Health and follow us on LinkedIn and X. Contact Information Andreia Beyer VP, Global Marketing & Managing Director, North America abeyer@ +1 (416) 565-0474 SOURCE: Tribun Health press release This story was originally published May 6, 2025 at 8:06 AM.
